These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37766174)

  • 1. Efficiency of NHEJ-CRISPR/Cas9 and Cre-LoxP Engineered Recombinant Turkey Herpesvirus Expressing
    Apinda N; Yao Y; Zhang Y; Muenthaisong A; Sangkakam K; Nambooppha B; Rittipornlertrak A; Koonyosying P; Nair V; Sthitmatee N
    Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Protective Immune Responses of Ducks against Duck Plague and Fowl Cholera by Recombinant Duck Enteritis Virus Vector Expressing
    Apinda N; Muenthaisong A; Chomjit P; Sangkakam K; Nambooppha B; Rittipornlertrak A; Koonyosying P; Yao Y; Nair V; Sthitmatee N
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 Editing of Duck Enteritis Virus Genome for the Construction of a Recombinant Vaccine Vector Expressing
    Apinda N; Yao Y; Zhang Y; Reddy VRAP; Chang P; Nair V; Sthitmatee N
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against fowl cholera in ducks immunized with a combination vaccine containing live attenuated duck enteritis virus and recombinant outer membrane protein H of
    Apinda N; Nambooppha B; Rittipornlertrak A; Tankaew P; Punyapornwithaya V; Nair V; Sawada T; Sthitmatee N
    Avian Pathol; 2020 Jun; 49(3):221-229. PubMed ID: 31899951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recombinant Turkey Herpesvirus Expressing the F Protein of Newcastle Disease Virus Genotype XII Generated by NHEJ-CRISPR/Cas9 and Cre-LoxP Systems Confers Protection against Genotype XII Challenge in Chickens.
    Calderón K; Rojas-Neyra A; Carbajal-Lévano B; Luján-Valenzuela L; Ticona J; Isasi-Rivas G; Montalvan A; Criollo-Orozco M; Huaccachi-Gonzáles E; Tataje-Lavanda L; Alvarez KLF; Fernández-Sánchez M; Fernández-Díaz M; Tang N; Yao Y; Nair V
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy of the recombinant
    Li Y; Xiao J; Chang YF; Zhang H; Teng Y; Lin W; Li H; Chen W; Zhang X; Xie Q
    Front Immunol; 2022; 13():985993. PubMed ID: 36275745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous construction strategy using two types of fluorescent markers for HVT vector vaccine against infectious bursal disease and H9N2 avian influenza virus by NHEJ-CRISPR/Cas9.
    Zhang JF; Shang K; Kim SW; Park JY; Wei B; Jang HK; Kang M; Cha SY
    Front Vet Sci; 2024; 11():1385958. PubMed ID: 38812565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ducks as a potential reservoir for Pasteurella multocida infection detected using a new rOmpH-based ELISA.
    Liu R; Chen C; Cheng L; Lu R; Fu G; Shi S; Chen H; Wan C; Lin J; Fu Q; Huang Y
    J Vet Med Sci; 2017 Jul; 79(7):1264-1271. PubMed ID: 28626158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer membrane protein H for protective immunity against Pasteurella multocida.
    Lee J; Kim YB; Kwon M
    J Microbiol; 2007 Apr; 45(2):179-84. PubMed ID: 17483806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward the development of polyvalent vaccination strategies against multiple viral infections in chickens using herpesvirus of turkeys as vector.
    Iqbal M
    Bioengineered; 2012; 3(4):222-6. PubMed ID: 22705840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and immune efficacy of a recombinant turkey herpesvirus vaccine strain expressing fusion protein of genotype VII Newcastle disease virus.
    Jia W; Zhang X; Wang H; Teng Q; Xue J; Zhang G
    Vet Microbiol; 2022 May; 268():109429. PubMed ID: 35421830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, expression and protective capacity of 37 kDa outer membrane protein gene (ompH) of Pasteurella multocida serotype B:2.
    Tan HY; Nagoor NH; Sekaran SD
    Trop Biomed; 2010 Dec; 27(3):430-41. PubMed ID: 21399583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses and protective efficacy of a novel DNA vaccine encoding outer membrane protein of avian Pasteurella multocida.
    Gong Q; Qu N; Niu M; Qin C; Cheng M; Sun X; Zhang A
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):317-24. PubMed ID: 23340446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurella multocida serogroups in mouse models.
    Wang Z; Wang M; Wang F; Luo Y; Liu H; Zhu Z; Huang X; Hua L; Chen H; Wu B; Peng Z
    Vaccine; 2024 Apr; 42(12):3075-3083. PubMed ID: 38584060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site.
    Gao H; Cui H; Cui X; Shi X; Zhao Y; Zhao X; Quan Y; Yan S; Zeng W; Wang Y
    PLoS One; 2011; 6(7):e22549. PubMed ID: 21818336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of Escherichia coli ghost of anchoring bovine Pasteurella multocida OmpH and its immunoprotective effect.
    Chen N; Jiang D; Liu Y; Zhang Z; Zhou Y; Zhu Z
    BMC Vet Res; 2023 Oct; 19(1):192. PubMed ID: 37803295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.
    Li Y; Reddy K; Reid SM; Cox WJ; Brown IH; Britton P; Nair V; Iqbal M
    Vaccine; 2011 Oct; 29(46):8257-66. PubMed ID: 21907750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
    PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.